JPH0120153B2 - - Google Patents
Info
- Publication number
- JPH0120153B2 JPH0120153B2 JP55080482A JP8048280A JPH0120153B2 JP H0120153 B2 JPH0120153 B2 JP H0120153B2 JP 55080482 A JP55080482 A JP 55080482A JP 8048280 A JP8048280 A JP 8048280A JP H0120153 B2 JPH0120153 B2 JP H0120153B2
- Authority
- JP
- Japan
- Prior art keywords
- chloroform
- acetone
- culture
- methanol
- silica gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/29—Micromonospora
- C12R2001/30—Micromonospora chalcea
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Furan Compounds (AREA)
- Saccharide Compounds (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8048280A JPS577479A (en) | 1980-06-14 | 1980-06-14 | Tetronolide compound |
US06/252,062 US4346075A (en) | 1980-06-14 | 1981-04-08 | Antibiotic DC-11 and process for production thereof |
EP81104619A EP0042172B1 (en) | 1980-06-14 | 1981-06-15 | Antibiotic compounds, pharmaceutical compositions containing such compounds, process for production thereof |
DE8181104619T DE3167053D1 (en) | 1980-06-14 | 1981-06-15 | Antibiotic compounds, pharmaceutical compositions containing such compounds, process for production thereof |
US06/273,377 US4393056A (en) | 1980-06-14 | 1981-06-15 | Antibiotics tetronolide compounds and process for production thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8048280A JPS577479A (en) | 1980-06-14 | 1980-06-14 | Tetronolide compound |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS577479A JPS577479A (en) | 1982-01-14 |
JPH0120153B2 true JPH0120153B2 (en, 2012) | 1989-04-14 |
Family
ID=13719489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8048280A Granted JPS577479A (en) | 1980-06-14 | 1980-06-14 | Tetronolide compound |
Country Status (4)
Country | Link |
---|---|
US (1) | US4393056A (en, 2012) |
EP (1) | EP0042172B1 (en, 2012) |
JP (1) | JPS577479A (en, 2012) |
DE (1) | DE3167053D1 (en, 2012) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5661398A (en) * | 1979-10-26 | 1981-05-26 | Kyowa Hakko Kogyo Co Ltd | Substance dc-45 and its preparation |
CA2342325A1 (en) * | 1998-08-31 | 2000-03-09 | Kyowa Hakko Kogyo Co., Ltd. | An agent for inducing apoptosis |
CN111170975B (zh) * | 2020-01-19 | 2021-11-23 | 中国科学院南海海洋研究所 | 抗生素lobophorin及其制备方法和应用 |
CN114180599B (zh) * | 2021-12-23 | 2023-04-14 | 江苏兄弟维生素有限公司 | 从硝酸硫胺母液中回收硝酸铵的工艺及应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3144466A (en) * | 1963-03-08 | 1964-08-11 | Pfizer & Co C | Diacyl esters of de-oleandrosehydroxyoleandomycin and process therefor |
DE2329012A1 (de) * | 1972-06-12 | 1973-12-20 | Scherico Ltd | Aminoglykosidantibiotika und ihre herstellung aus micromonospora |
US4161523A (en) * | 1972-11-15 | 1979-07-17 | Schering Corporation | Rosamicin esters, acid addition salts and methods for production thereof |
JPS54138501A (en) * | 1978-04-20 | 1979-10-27 | Kyowa Hakko Kogyo Co Ltd | Antibiotic dc-11 and preparation thereof |
US4346075A (en) * | 1980-06-14 | 1982-08-24 | Kyowa Hakko Kogyo Co., Ltd. | Antibiotic DC-11 and process for production thereof |
-
1980
- 1980-06-14 JP JP8048280A patent/JPS577479A/ja active Granted
-
1981
- 1981-06-15 US US06/273,377 patent/US4393056A/en not_active Expired - Fee Related
- 1981-06-15 DE DE8181104619T patent/DE3167053D1/de not_active Expired
- 1981-06-15 EP EP81104619A patent/EP0042172B1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS577479A (en) | 1982-01-14 |
EP0042172A1 (en) | 1981-12-23 |
US4393056A (en) | 1983-07-12 |
EP0042172B1 (en) | 1984-11-07 |
DE3167053D1 (en) | 1984-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4521145B2 (ja) | 抗生物質カプラザマイシン類およびその製造法 | |
KR100230961B1 (ko) | 신규한 아미노올리고당 유도체 및 그의 제조방법 | |
JPS61236792A (ja) | 新規アントラサイクリン抗生物質 | |
US4578383A (en) | CL 1565 antibiotic compounds | |
EP0087021B1 (en) | Cl 1565 antibiotic compounds and their production | |
JPH0120153B2 (en, 2012) | ||
JPH03141290A (ja) | 抗腫瘍抗生物質bmy―41339 | |
JPS5948992B2 (ja) | 抗生物質c−14482a↓1 | |
JPS6253518B2 (en, 2012) | ||
JP2592468B2 (ja) | 新規抗生物質ベナノマイシンaおよびbならびにその製造法 | |
JPS6253519B2 (en, 2012) | ||
JPS6212227B2 (en, 2012) | ||
JP3100785B2 (ja) | 新規エバーメクチン誘導体、その製造方法ならびにその生産微生物 | |
JP2594085B2 (ja) | 新規抗腫瘍抗生物質sf2575物質ならびにその製造法 | |
JPH0367077B2 (en, 2012) | ||
JPH09157266A (ja) | 新規抗生物質エポキシキノマイシンaおよびbとその製造法 | |
US4696912A (en) | Stabilized compositions | |
JPH02200655A (ja) | 新規物質uct−1003 | |
JPS6338038B2 (en, 2012) | ||
JPH0625277A (ja) | 新規テストステロン−5α−レダクターゼ阻害物質SNA−4606産生菌、新規テストステロン−5α−レダクターゼ阻害物質SNA−4606及びその製造法 | |
JPS6317075B2 (en, 2012) | ||
JPS61170396A (ja) | 新規な制癌性抗生物質83−16−aおよびその製造法 | |
JPH039110B2 (en, 2012) | ||
JPS5915634B2 (ja) | 発酵法によるアクチノマイシンの製造法 | |
JP2001055386A (ja) | 抗生物質ツベラクトマイシンb、dおよびeとその製造法 |